STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Clinical trials for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests daily pill to stop lung Cancer's return
Disease control OngoingThis large study is testing whether taking a daily pill called erlotinib for two years after lung cancer surgery helps patients live longer. It compares the pill to just regular check-ups (observation) in patients whose cancer has a specific genetic change (EGFR mutation). The go…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Major trial tests immune therapy to stop lung Cancer's comeback
Disease control OngoingThis large Phase 3 trial tested whether giving the immunotherapy drug nivolumab after surgery and chemotherapy could help prevent lung cancer from returning. It involved 903 patients with stage IB-IIIA non-small cell lung cancer who had their tumors surgically removed. The study …
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Massive study maps lung cancer genes to personalize future care
Knowledge-focused OngoingThis large study aims to understand the genetic makeup of lung cancer tumors after they have been surgically removed. It will test tumor samples from 8,300 patients with early-stage non-small cell lung cancer to identify specific genetic changes. The goal is to use this genetic i…
Matched conditions: STAGE IB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC